<?xml version="1.0"?>
<Articles JournalTitle="International Journal of Hematology-Oncology and Stem Cell Research">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>2</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2005</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Survey of 121 patients with Idiopathic Thrombocytopenic Purpura</title>
    <FirstPage>1</FirstPage>
    <LastPage>4</LastPage>
    <AuthorList>
      <Author>
        <FirstName>A</FirstName>
        <LastName>Shahriariahmadi</LastName>
        <affiliation locale="en_US">Department of Hematology&#x2013;Oncology, Taleghani Hospital, Kermanshah University of Medical Science, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>M</FirstName>
        <LastName>Tahmasian</LastName>
        <affiliation locale="en_US">Department of Hematology&#x2013;Oncology, Taleghani Hospital, Kermanshah University of Medical Science, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Introduction: Idiopathic Thrombocytopenic Purpura is one of the most common causes of thrombocy-topenia with varius clinical courses and different responses to its treatment modalities. Therefore, we decided to evaluate the clinical course of this disease in our patients.
Methods: In this case series study, from March 1998 to March 2004, we evaluated 121 patients. As a first line of treatment, all of those patients received prednisolone (1mg/kg/day) for 6 weeks. Those who didn't respond or were refractory to prednisolone were candidates for splenectomy, and those who re&#xAC;fused these modalities or didn't respond to them were treated with Azathioprine. 
Results: 99 patients (81.8%) were female and 22 (18.2%) were male, aged 11-73 years (mean; 28.6). Two patients had immune hemolytic anemia in addition to thrombocytopenia, 4 had systemic lupus erythematosus, and one was HIV positive. %44.6 of patients fully responded to prednisolone, 42 pa&#xAC;tients (%34.7) underwent splenectomy and %83.3 of them responsed to it.31 splenectomies were per&#xAC;formed in the first three months after diagnosis and 27 (87.1%) of them showed complete response, but 8 (72.7%) of the patients splenectomized after 3 months, had complete response. 14 patients were treated with Azathoprine, 2 of which (14.3%) platelet count normalized.
Conclusion: ITP is more common in females than males. Prednisolone is preferred as a non-invasive treatment with suitable response in comparison to other modalition responses to splenectomy, indicat&#xAC;ing that this modality of treatment is useful and effective, especially when performaed in the first 3 months of the diseases.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/184</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/184/177</pdf_url>
  </Article>
</Articles>
